This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hrabák, J.
Right arrow Articles by Urbásková, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hrabák, J.
Right arrow Articles by Urbásková, P.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2008, p. 2147-2148, Vol. 46, No. 6
0095-1137/08/$08.00+0     doi:10.1128/JCM.00427-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

CTX-M-15-Producing Shigella sonnei Strain from a Czech Patient Who Traveled in Asia {triangledown}


arrow
LETTER
 
International travel has been recognized as an important factor in the diffusion of multiresistant bacteria, including organisms that produce extended-spectrum β-lactamases (ESBLs) (14, 15, 16). When followed by clonal spread and/or horizontal transfer of ESBL-encoding plasmids in new areas, it may contribute to the global "epidemiologic success" of particular ESBL types. This is probably the case for some of the CTX-M enzymes (e.g., CTX-M-15), a family of derivatives of natural β-lactamases of Kluyvera spp. (3, 12). Here we report the first identification of ESBL-producing Shigella sonnei in the Czech Republic, from a 31-year-old female who traveled to China, Nepal, and India in April and May 2006. Immediately after returning, she was admitted with diarrhea and vomiting to a regional hospital. S. sonnei was cultured from stool; the identification was performed by ENTEROtest 24 (Pliva-Lachema Diagnostika, Brno, Czech Republic) and Shigella sonnei Polyvalent D (Denka Seiken, Tokyo, Japan). The isolate was found to produce ESBL with the double-disk synergy test (10). MICs of various antimicrobials, determined by the CLSI microdilution method (5), showed a classical ESBL-mediated pattern of β-lactam resistance, including cefotaxime and ceftazidime (Table 1). The patient, not treated with antibiotics, recovered in 21 days.


View this table:
[in this window]
[in a new window]

  		TABLE 1. Antimicrobial susceptibility of the S. sonnei isolate described here

The isolate was subjected to mating with Escherichia coli A15 Rifr as previously described (8); cefotaxime- and rifampin-resistant transconjugants were obtained at a frequency of 10–4 per donor cell. Isoelectric focusing (2) revealed that both the S. sonnei isolate and its transconjugant expressed β-lactamases with pIs of 8.9 and 5.4, of which the pI 8.9 enzyme hydrolyzed cefotaxime and ceftazidime in the overlay assay (2). PCR with primers P1C and P2D, which are specific for blaCTX-M-1-like genes (8), followed by DNA sequencing, identified the enzyme as CTX-M-15, which is encoded by a gene identical to those originally reported (1, 11). Owing to the Glu240Gly mutation, CTX-M-15 belongs to the CTX-M enzymes with significant ceftazidime-hydrolyzing activity (7, 13). PCR and sequencing of the 5' flank of blaCTX-M-15, carried out as described previously (1), showed an ISEcp1 element placed 48 bp upstream from the gene. Such a genetic arrangement, suggesting a single ISEcp1-mediated escape of blaCTX-M-15 from Kluyvera spp., has been found in enterobacteria from many countries (12), including India, where CTX-M-15 was identified originally (11). Plasmid replicon typing (4), performed with the transconjugant's DNA, revealed the presence of a sole FII replicon, characteristic for plasmids that are associated with the worldwide spread of blaCTX-M-15 genes (6, 9). However, in contrast to many molecules of that type (6, 9), the plasmid did not transmit any other resistance from the S. sonnei isolate (Table 1) apart from that to β-lactams (data not shown).

This report documents the repeated importation of a CTX-M-15 producer to Europe, where organisms with the same context of blaCTX-M-15, mostly E. coli, have already been disseminating (12), also in the Czech Republic (J.H., J.E., M.G., and P.U., unpublished data). It demonstrates further that the ongoing flow of ESBL-producing bacteria between different regions, including their constant supply from high-prevalence areas, makes the control of their wide spread enormously difficult.


arrow
ACKNOWLEDGMENTS
 
The study reported here was partially financed by research project grant MSM 0021620819 from the Ministry of Education, Czech Republic. J.E. and M.G. were partially supported by grant 6 PRCD LSHM-CT-2003-503-335 (COBRA) from the European Commission.


arrow
FOOTNOTES
 
{triangledown} Published ahead of print on 23 April 2008. Back


arrow
REFERENCES
 
    1
  1. Baraniak, A., J. Fiett, W. Hryniewicz, P. Nordmann, and M. Gniadkowski. 2002. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum β-lactamase (ESBL) in Poland. J. Antimicrob. Chemother. 50:393-396.[Abstract/Free Full Text]
    2. 2
  2. Bauernfeind, A., H. Grimm, and S. Schweighart. 1990. A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. Infection 18:294-298.[CrossRef][Medline]
    3. 3
  3. Bonnet, R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.[Free Full Text]
    4. 4
  4. Carattoli, A., A. Bertini, L. Villa, V. Falbo, K. L. Hopkins, and E. J. Threlfall. 2005. Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods 63:219-228.[CrossRef][Medline]
    5. 5
  5. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. CLSI document M100-S-16. Clinical and Laboratory Standards Institute, Wayne, PA.
    6. 6
  6. Coque, T. M., A. Novais, A. Carattoli, L. Poirel, J. Pitout, L. Peixe, F. Baquero, R. Cantón, and P. Nordmann. 2008. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg. Infect. Dis. 14:195-200.[Medline]
    7. 7
  7. Gniadkowski, M. 2008. Evolution of extended-spectrum β-lactamases (ESBLs) by mutation. Clin. Microbiol. Infect. 14(Suppl. 1):11-32.[CrossRef][Medline]
    8. 8
  8. Gniadkowski, M., I. Schneider, A. Palucha, R. Jungwirth, B. Mikiewicz, and A. Bauernfeind. 1998. Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing β-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme. Antimicrob. Agents Chemother. 42:827-832.[Abstract/Free Full Text]
    9. 9
  9. Hopkins, K. L., E. Liebana, L. Villa, M. Batchelor, E. J. Threlfall, and A. Carattoli. 2006. Replicon typing of plasmids carrying CTX-M or CMY β-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob. Agents Chemother. 50:3203-3206.[Abstract/Free Full Text]
    10. 10
  10. Jarlier, V., M. Nicolas, G. Fournier, and A. Philippon. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.[Medline]
    11. 11
  11. Karim, A., L. Poirel, S. Nagarajan, and P. Nordmann. 2001. Plasmid-mediated extended-spectrum β-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol. Lett. 201:237-241.[Medline]
    12. 12
  12. Livermore, D. M., R. Cantón, M. Gniadkowski, P. Nordmann, G. M. Rossolini, G. Arlet, J. Ayala, T. M. Coque, I. Kern-Zdanowicz, F. Luzzaro, L. Poirel, and N. Woodford. 2007. CTX-M: changing the face of ESBLs in Europe. J. Antimicrob. Chemother. 59:165-174.[Abstract/Free Full Text]
    13. 13
  13. Poirel, L., M. Gniadkowski, and P. Nordmann. 2002. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum β-lactamase CTX-M-15 and of its structurally related β-lactamase CTX-M-3. J. Antimicrob. Chemother. 50:1031-1034.[Abstract/Free Full Text]
    14. 14
  14. Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632.[Abstract/Free Full Text]
    15. 15
  15. Poirel, L., T. Naas, M. Guibert, E. B. Chaibi, R. Labia, and P. Nordmann. 1999. Molecular and biochemical characterization of VEB-1, a novel class A extended-spectrum β-lactamase encoded by an Escherichia coli integron gene. Antimicrob. Agents Chemother. 43:573-581.[Abstract/Free Full Text]
    16. 16
  16. Tassios, P. T., M. Gazouli, E. Tzelepi, H. Milch, N. Kozlova, S. Sidorenko, N. J. Legakis, and L. S. Tzouvelekis. 1999. Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries. J. Clin. Microbiol. 37:3774-3777.[Abstract/Free Full Text]
Jaroslav Hrabák*
Department of Microbiology
Faculty of Medicine in Plzen
Charles University in Prague
Plzen 305 99, Czech Republic

Joanna Empel
Marek Gniadkowski
Department of Molecular Microbiology
National Medicines Institute
Warsaw 00-725, Poland,1

Zbynek Halbhuber
Karel Rébl
Department of Clinical Microbiology
Institute of Health in Kolín
Kladno 272 01, Czech Republic,2

Pavla Urbásková
National Reference Laboratory for Antibiotics
National Institute of Health
Praha 100 42, Czech Republic,3

* Phone: 420 377 40 29 32
Fax: 420 377 10 32 50
E-mail: Jaroslav.Hrabak{at}lfp.cuni.cz

Journal of Clinical Microbiology, June 2008, p. 2147-2148, Vol. 46, No. 6
0095-1137/08/$08.00+0     doi:10.1128/JCM.00427-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Carattoli, A. (2009). Resistance Plasmid Families in Enterobacteriaceae. Antimicrob. Agents Chemother. 53: 2227-2238 [Full Text]  
  • Pitout, J. D. D., Campbell, L., Church, D. L., Gregson, D. B., Laupland, K. B. (2009). Molecular Characteristics of Travel-Related Extended-Spectrum-{beta}-Lactamase-Producing Escherichia coli Isolates from the Calgary Health Region. Antimicrob. Agents Chemother. 53: 2539-2543 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hrabák, J.
Right arrow Articles by Urbásková, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hrabák, J.
Right arrow Articles by Urbásková, P.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»